1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Elicio Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors ELI-002 7P - Pancreatic Ductal Adenocarcinoma, Colorectal Cancer | Phase 1 / Phase 2 | Active not recruiting | Elicio Therapeutics | 158 | 2023-04-14 | 2026-07-10 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Rectal Neoplasms (1)
United States (1)